Thomas M Habermann (Thomas Habermann)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Diffuse Large B Cell Lymphoma

Helicobacter Pylori

Top Venues

American journal of hematology

Blood cancer journal

JCO oncology practice

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice (2024)
Karan L Chohan, Rajiv K Pruthi, Saurabh Zanwar, Jonas Paludo, Ronald S Go, Animesh Pardanani, Aneel Ashrani, Joselle Madonna Cook, Carrie A Thompson, Asher Chanan-Khan, Sikandar Ailawadhi, Thomas M Habermann, Thomas E Witzig, Morie A Gertz, David Dingli, Francis K Buadi, Angela Dispenzieri, Nelson R Leung, Shaji K Kumar, Sundararajan Vincent Rajkumar, William L Nichols, Robert A Kyle, Stephen M Ansell, Prashant Kapoor, Meera Sridharan, Jithma A Abeykoon
The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events. Leukemia (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice 20 (8) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Chonlada Laoruangroj, Thomas M Habermann, Yucai Wang, Rebecca L King, Scott C Lester, Carrie A Thompson, Thomas E Witzig
Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori ? JCO oncology practice 20 (8) (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Vanja Zeremski, Ellen Darcy McPhail, Thomas M Habermann, Francesca Schieppati, Niklas Gebauer, Theodoros P Vassilakopoulos, Dimitrios Mougiakakos
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis. Hematological oncology (2023)
Allison M Bock, Jennifer Jane Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew John Maurer, Brian F Kabat, Jonas Paludo, David J Inwards, Sabarish Ayyappan, Brian K Link, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, James R Cerhan, Umar Farooq, Yucai Wang
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Nadine H Abdallah, Thomas M Habermann, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Sundararajan Vincent Rajkumar, David Dingli, Ronald S Go, Suzanne R Hayman, Shaji K Kumar, Taxiarchis V Kourelis, Rahma M Warsame, Prashant Kapoor, Eli Muchtar, Yi Lisa Hwa, Amie L Fonder, Miriam A Hobbs, Yi Lin, Nelson R Leung, Moritz Binder, Mustaqeem A Siddiqui, Robert A Kyle, Thomas E Witzig, Angela Dispenzieri
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation. American journal of hematology 97 (4) (2022)
Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, Umair Majeed, Jing Wang, Liuyan Jiang, Justin J Kuhlman, David Menke, Ke Li, Mohamed A Kharfan-Dabaja, Ernesto Ayala, Madiha Iqbal, Grzegorz S Nowakowski, Thomas M Habermann, Thomas E Witzig, Patrick Johnston, Carrie Thompson, Stephen M Ansell, Han W Tun
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018). American journal of hematology 97 (9) (2022)
Juan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, Brian K Link, Catherine Thieblemont, Annarita Conconi, Melissa C Larson, Luciano Cascione, Wei Zhao, James R Cerhan, Emanuele Zucca, Izidore S Lossos
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. American journal of hematology 97 (12) (2022)
Juan Pablo Alderuccio, Thomas M Habermann, Russ Kuker, Craig H Moskowitz, Andrew D Zelenetz, Izidore S Lossos
A roadmap for clinical trial design in marginal zone lymphoma. American journal of hematology 97 (11) (2022)
Darragh F O'Donoghue, Huong L Truong, Heidi D Finnes, Jennifer S McDonald, Heather Personett May, Stephen M Ansell, N Nora Bennani, Thomas M Habermann, David J Inwards, Patrick B Johnston, Arushi Khurana, Yi Lin, Ivana N Micallef, Grzegorz S Nowakowski, Jonas Paludo, Luis F Porrata, Gita Thanarajasingam, Carrie A Thompson, Jose C Villasboas Bisneto, Yucai Wang, Thomas E Witzig, Nelson R Leung
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course. JCO oncology practice (2022)
Arushi Khurana, Matthew Hathcock, Thomas M Habermann, Abdullah S Al Saleh, Sangeetha Gandhi, Tuan Truong, N Nora Bennani, Jonas Paludo, Jose C Villasboas, Stephen M Ansell, David J Inwards, Luis F Porrata, Patrick B Johnston, Ivana Micallef, Yi Lin
Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma. American journal of hematology 96 (10) (2021)
Matthew Ho, Saurabh Zanwar, Patrick Duggan, Ryan Carr, Thomas M Habermann, Patrick J Navin, Mohamed E Salama, Sameer A Parikh
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma. American journal of hematology (2021)